{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:52:51Z","timestamp":1768589571562,"version":"3.49.0"},"reference-count":287,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146374","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:51:14Z","timestamp":1753728674000},"page":"146374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P2","title":["Stromal-derived factor-1: The glycoprotein fueling autoimmune storms via CXCR4 and CXCR7"],"prefix":"10.1016","volume":"321","author":[{"given":"Mitra","family":"Abbasifard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Mohammadi-Shahrokhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijbiomac.2025.146374_bb0005","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.3390\/ijms25147666","article-title":"Understanding autoimmunity: mechanisms, predisposing factors, and cytokine therapies","volume":"25","author":"Yasmeen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0010","first-page":"852","article-title":"The Role of Cytokines in Autoimmune Diseases: Pathogenesis and Therapeutic Implications","volume":"6","author":"Faqri","year":"2025","journal-title":"Central Asian Journal of Medical and Natural Sciences"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156770","article-title":"Chemokines and chemokine receptors: potential therapeutic targets in systemic lupus erythematosus","volume":"184","author":"Duan","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0020","doi-asserted-by":"crossref","first-page":"100053","DOI":"10.1016\/j.molpha.2025.100053","article-title":"Chemokine receptors\u2013exemplifying functional divergence in GPCRs","author":"Otun","year":"2025","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146374_bb0025","first-page":"1555","article-title":"THE ROLE OF CYTOKINES IN THE DEVELOPMENT OF AUTOIMMUNE DISORDERS","volume":"4","author":"Sultanov","year":"2025","journal-title":"Modern Science and Research"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1042\/BST0340997","article-title":"Natural post-translational modifications of chemokines","volume":"34","author":"Proost","year":"2006","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12031-011-9672-6","article-title":"The SDF-1 3\u2032 a genetic variation of the chemokine SDF-1\u03b1 (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients","volume":"47","author":"Azin","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0897.2012.01167.x","article-title":"Differential expression of CXC chemokines CXCL 10 and CXCL 12 in term and pre-term neonates and their mothers","volume":"68","author":"Aminzadeh","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2012.05.200","article-title":"Assessment of CXCL12 (SDF-1\u03b1) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran","volume":"16","author":"Hassanshahi","year":"2012","journal-title":"Int. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000494435","article-title":"CXCL12 and CXCR4 in the peripheral blood of patients with Parkinson\u2019s disease","volume":"25","author":"Bagheri","year":"2019","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0055","first-page":"C987","article-title":"Stroma-derived factor (SDF-1\/CXCL12) and human tumor pathogenesis","volume":"292","author":"Kryczek","year":"2007","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb0060","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2174\/1381612043452640","article-title":"Chemokines and their receptors as therapeutic targets: the role of the SDF-1\/CXCR4 axis","volume":"10","author":"Juarez","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0065","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1007\/s00432-022-04444-w","article-title":"CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment","volume":"149","author":"Bao","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12672-025-02324-6","article-title":"CXCR7 promoted proliferation, migration and invasion in HCC Cells by inactivating Hippo-YAP signaling","volume":"16","author":"Wang","year":"2025","journal-title":"Discov. Oncol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb0075","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2015.11.021","article-title":"New insights into the role of stromal cell-derived factor 1 (SDF-1\/CXCL12) in the pathophysiology of multiple sclerosis","volume":"290","author":"Khorramdelazad","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0085","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/med.22011","article-title":"CXCR4\/CXCL12 axis:\u201cold\u201d pathway as \u201cnovel\u201d target for anti-inflammatory drug discovery","volume":"44","author":"Lu","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13578-025-01398-7","article-title":"The regulatory functions of G protein-coupled receptors signaling pathways in B cell differentiation and development contributing to autoimmune diseases","volume":"15","author":"Shao","year":"2025","journal-title":"Cell Biosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2007.12.043","article-title":"Chemokine receptor expression on infiltrating lymphocytes from abdominal aortic aneurysms: Role of CXCR4\u2013CXCL12 in lymphoid recruitment","volume":"200","author":"Oca\u00f1a","year":"2008","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0100","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1039\/D4BM01474J","article-title":"Modulation of biomaterial-induced foreign body response by regulating the differentiation and migration of Treg cells through the CXCL12\u2013CXCR4\/7 axis","volume":"13","author":"Yu","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0105","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fendo.2019.00585","article-title":"The role of the CXCL12\/CXCR4\/ACKR3 axis in autoimmune diseases","volume":"10","author":"Garc\u00eda-Cuesta","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146374_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114578","article-title":"Cryo-EM structure of monomeric CXCL12-bound CXCR4 in the active state","volume":"43","author":"Liu","year":"2024","journal-title":"Cell Rep."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.146374_bb0115","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.3390\/ijms21228680","article-title":"Increased CXC motif chemokine ligand 12 levels in cerebrospinal fluid as a candidate biomarker in sporadic amyotrophic lateral sclerosis","volume":"21","author":"Andr\u00e9s-Benito","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12551-024-01230-5","article-title":"The influence of SDF-1 (CXCL12) gene in health and disease: a review of literature","volume":"17","author":"Biyani","year":"2025","journal-title":"Biophys. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12935-024-03584-y","article-title":"A1, an innovative fluorinated CXCR4 inhibitor, redefines the therapeutic landscape in colorectal cancer","volume":"25","author":"Khorramdelazad","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123216","article-title":"Immunity\/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12\/CXCR4 and adenosine-A2AR pathways","volume":"319","author":"Wei","year":"2025","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0135","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/ijms25031705","article-title":"CXCL12 neutralizing antibody promotes hair growth in androgenic alopecia and alopecia areata","volume":"25","author":"Zheng","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0140","series-title":"Development of RNA-based Nanoparticles for Cancer Therapy","author":"Sim\u00f5es","year":"2023"},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2025.146374_bb0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-4274(02)00432-0","article-title":"Chemokines and their receptors in the CNS: expression of CXCL12\/SDF-1 and CXCR4 and their role in astrocyte proliferation","volume":"139","author":"Bonavia","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0150","series-title":"Structural and functional study of the interaction between CXCL12 chemokine and its receptors: CXCR4 and ACKR3\/CXCR7","author":"Cutolo","year":"2016"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001110","article-title":"The novel CXCL12\u03b3 isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4","volume":"2","author":"Laguri","year":"2007","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0160","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3390\/ijms18102088","article-title":"Chemokines from a structural perspective","volume":"18","author":"Miller","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb0165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/092986711794480159","article-title":"The CXCL12\/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection","volume":"18","author":"Patrussi","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"6007","key":"10.1016\/j.ijbiomac.2025.146374_bb0170","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0175","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/vaccines11030671","article-title":"Structural and phylogenetic analysis of CXCR4 protein reveals new insights into its role in emerging and Re-emerging diseases in mammals","volume":"11","author":"Naheed","year":"2023","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146374_bb0180","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1039\/c3mb70120d","article-title":"Structural basis of the interactions between CXCR4 and CXCL12\/SDF-1 revealed by theoretical approaches","volume":"9","author":"Xu","year":"2013","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0185","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fphar.2018.00641","article-title":"CXCR7 targeting and its major disease relevance","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0190","series-title":"Molecular Insights Into Recognition, Activation and Function of the Atypical Chemokine Receptor CXCR7\/ACKR3","first-page":"93","article-title":"C., modifications: role in chemokine binding and receptor activation","author":"N terminus post-translational","year":"2016"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0195","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/ehm.10.16","article-title":"CXCL12 and CXCR4 in bone marrow physiology","volume":"3","author":"Moll","year":"2010","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0200","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s11481-011-9336-x","article-title":"CXCL12 signaling in the development of the nervous system","volume":"7","author":"Mithal","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2018.10.004","article-title":"Pathological roles of the homeostatic chemokine CXCL12","volume":"44","author":"Janssens","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0210","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3389\/fimmu.2020.02109","article-title":"The chemokine receptor CXCR4 in cell proliferation and tissue regeneration","volume":"11","author":"Bianchi","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cyto.2014.06.007","article-title":"The role of CXCL12 and CCL7 chemokines in immune regulation, embryonic development, and tissue regeneration","volume":"69","author":"Cheng","year":"2014","journal-title":"Cytokine"},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.146374_bb0220","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1111\/febs.13043","article-title":"Processing of CXCL 12 impedes the recruitment of endothelial progenitor cells in diabetic wound healing","volume":"281","author":"Feng","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117534","article-title":"CXCL12\/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis","volume":"249","author":"Mortezaee","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.574667","article-title":"The role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0235","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10585-014-9639-4","article-title":"Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer","volume":"31","author":"Rupertus","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146374_bb0240","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2174\/1566524016666160829153453","article-title":"CXCR7 participates in CXCL12-mediated cell cycle and proliferation regulation in mouse neural progenitor cells","volume":"16","author":"Wang","year":"2016","journal-title":"Curr. Mol. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034192","article-title":"Ubiquitination of CXCR7 controls receptor trafficking","volume":"7","author":"Canals","year":"2012","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.ijbiomac.2025.146374_bb0250","doi-asserted-by":"crossref","first-page":"28362","DOI":"10.1074\/jbc.M111.335679","article-title":"Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine\/threonine residues","volume":"287","author":"Hoffmann","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.146374_bb0255","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1242\/dev.080408","article-title":"\u03b2-arrestin control of late endosomal sorting facilitates decoy receptor function and chemokine gradient formation","volume":"139","author":"Mahabaleshwar","year":"2012","journal-title":"Development"},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2025.146374_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2009.04.071","article-title":"The role of stromal-derived factor-1\u2014CXCR7 axis in development and cancer","volume":"625","author":"Maksym","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-29-31","article-title":"Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells","volume":"29","author":"Zheng","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.146374_bb0270","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCULATIONAHA.116.023027","article-title":"Loss of endothelial CXCR7 impairs vascular homeostasis and cardiac remodeling after myocardial infarction: implications for cardiovascular drug discovery","volume":"135","author":"Hao","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb0275","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3390\/cancers14092314","article-title":"CXCR4\/CXCL12 activities in the tumor microenvironment and implications for tumor immunotherapy","volume":"14","author":"Mezzapelle","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0280","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00011-016-1011-5","article-title":"G protein coupled receptors signaling pathways implicate in inflammatory and immune response of rheumatoid arthritis","volume":"66","author":"Shu","year":"2017","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imlet.2019.11.007","article-title":"CXCL12\/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy","volume":"217","author":"Mousavi","year":"2020","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0290","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1002\/jcb.28253","article-title":"CXCL12\/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K\/AKT signal pathway","volume":"120","author":"Yin","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0295","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/07357907.2017.1422512","article-title":"Knockdown of CXCR4 inhibits CXCL12-induced angiogenesis in HUVECs through downregulation of the MAPK\/ERK and PI3K\/AKT and the Wnt\/\u03b2-catenin pathways","volume":"36","author":"Song","year":"2018","journal-title":"Cancer Investig."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146374_bb0300","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.immuni.2007.09.011","article-title":"SOCS3 protein developmentally regulates the chemokine receptor CXCR4-FAK signaling pathway during B lymphopoiesis","volume":"27","author":"Le","year":"2007","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.146374_bb0305","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1096\/fasebj.13.13.1699","article-title":"The chemokine SDF-l\u03b1 triggers CXCR4 receptor dimerization and activates the JAK\/STAT pathway","volume":"13","author":"Vila-Coro","year":"1999","journal-title":"FASEB J."},{"issue":"9b","key":"10.1016\/j.ijbiomac.2025.146374_bb0310","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1111\/j.1582-4934.2009.00691.x","article-title":"Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy","volume":"13","author":"Wu","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0315","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1189\/jlb.0606373","article-title":"GRKs and arrestins: regulators of migration and inflammation","volume":"80","author":"Vroon","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb0320","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41388-023-02597-7","article-title":"CXCR7 as a novel therapeutic target for advanced prostate cancer","volume":"42","author":"Gritsina","year":"2023","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146374_bb0325","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3390\/cancers14071810","article-title":"Colorectal cancer: the contribution of CXCL12 and its receptors CXCR4 and CXCR7","volume":"14","author":"Go\u00efta","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0330","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10147-017-1187-x","article-title":"Biological\/pathological functions of the CXCL12\/CXCR4\/CXCR7 axes in the pathogenesis of bladder cancer","volume":"22","author":"Nazari","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0335","first-page":"1","article-title":"Antitumor activities of a novel fluorinated small molecule (A1) in CT26 colorectal cancer cells: molecular docking and in vitro studies","author":"Khorramdelazad","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0340","series-title":"<POS0524 CXCL12 and CXCR4 AS Novel Biomarkers in Patients With Gouty Arthritis","author":"Kim","year":"2023"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146374_bb0345","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/pros.23781","article-title":"Inhibition of the CXCL12\/CXCR4 axis prevents periurethral collagen accumulation and lower urinary tract dysfunction in vivo","volume":"79","author":"Macoska","year":"2019","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0350","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/art.10520","article-title":"Hypoxia-induced production of stromal cell\u2013derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts","volume":"46","author":"Hitchon","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146374_bb0355","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb0360","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1002\/art.27650","article-title":"Pathogenic role of CXCR7 in rheumatoid arthritis","volume":"62","author":"Watanabe","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0365","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.4049\/jimmunol.165.6.3423","article-title":"Persistent induction of the chemokine receptor CXCR4 by TGF-\u03b21 on synovial T cells contributes to their accumulation within the rheumatoid synovium","volume":"165","author":"Buckley","year":"2000","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb0370","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4049\/jimmunol.170.4.2147","article-title":"Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis","volume":"170","author":"Pablos","year":"2003","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb0375","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105092","article-title":"Relevance of the CXCR4\/CXCR7-CXCL12 axis and its effect in pathophysiological conditions","volume":"161","author":"Huynh","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102923","article-title":"Synovial gene signatures associated with the development of rheumatoid arthritis in at risk individuals: a prospective study","volume":"133","author":"de Jong","year":"2022","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb0390","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0395","first-page":"739","article-title":"Serum level of CXCL12 in rheumatoid arthritis patients and its correlation with disease activity","volume":"30","author":"Nasr","year":"2024","journal-title":"Zagazig University Medical Journal"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0400","first-page":"1925","article-title":"Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity","volume":"20","author":"Peng","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0405","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cyto.2010.06.006","article-title":"CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts","volume":"53","author":"Santiago","year":"2011","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0410","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4049\/jimmunol.182.1.666","article-title":"Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4","volume":"182","author":"Struyf","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0415","first-page":"666","article-title":"Citrullination of CXCL12 differentially","volume":"182","author":"via CXCR, A","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0420","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4049\/jimmunol.182.1.666","article-title":"Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4","volume":"182","author":"Struyf","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0425","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/art.38750","article-title":"Citrullination of epithelial neutrophil\u2013activating peptide 78\/CXCL5 results in conversion from a non\u2013monocyte-recruiting chemokine to a monocyte-recruiting chemokine","volume":"66","author":"Yoshida","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0430","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jcp.10445","article-title":"CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients","volume":"199","author":"Grassi","year":"2004","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0435","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","article-title":"Cardiovascular disease in autoimmune rheumatic diseases","volume":"12","author":"Hollan","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0440","first-page":"27(4)","article-title":"The Relationship of Inflammatory Chemokine, CXCL12, with NT-proBNP: A Marker of Congestive Heart Failure in Rheumatoid Arthritis Patients","author":"Hassan","year":"2023","journal-title":"J. Kerman Univ. Med. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb0445","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1136\/annrheumdis-2015-207851","article-title":"Association of chemokine CXC ligand 12 gene polymorphism (rs1746048) with cardiovascular mortality in patients with rheumatoid arthritis: results from the Norfolk Arthritis Register","volume":"74","author":"Ibrahim","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0450","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13550-025-01203-z","article-title":"CXCR4-targeted PET imaging in rheumatoid arthritis: a novel approach for monitoring disease activity and therapeutic response","volume":"15","author":"Han","year":"2025","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0455","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211007687","article-title":"Inflammation in multiple sclerosis","volume":"14","author":"Haase","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb0460","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/neurosci3040048","article-title":"Cognitive impairment in multiple sclerosis: an update on assessment and management","volume":"3","author":"Portaccio","year":"2022","journal-title":"NeuroSci"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0465","series-title":"Bridging Cognitive Gaps: Development of Novel Diagnostic Criteria for MCI in Multiple Sclerosis","author":"Carta","year":"2025"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.737211","article-title":"Systematic review of the socioeconomic consequences in patients with multiple sclerosis with different levels of disability and cognitive function","volume":"12","author":"Kavaliunas","year":"2022","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb0475","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14737175.2021.1978843","article-title":"Role of environmental factors in multiple sclerosis","volume":"21","author":"Zarghami","year":"2021","journal-title":"Expert. Rev. Neurother."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb0480","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","article-title":"Genetics of multiple sclerosis: lessons from polygenicity","volume":"21","author":"Goris","year":"2022","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0485","doi-asserted-by":"crossref","first-page":"1503808","DOI":"10.3389\/fimmu.2024.1503808","article-title":"Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis","volume":"15","author":"Rasheed","year":"2024","journal-title":"Front. Immunol."},{"issue":"6578","key":"10.1016\/j.ijbiomac.2025.146374_bb0490","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0495","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5114\/pja.2023.131708","article-title":"The role of cytokines and chemokines in the inflammatory response","volume":"10","author":"Harvanov\u00e1","year":"2023","journal-title":"Alergologia Polska-Polish Journal of Allergology"},{"issue":"9\u201310","key":"10.1016\/j.ijbiomac.2025.146374_bb0500","first-page":"993","article-title":"Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients","volume":"59","author":"Jamali","year":"2013","journal-title":"Clin. Lab."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0505","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbadis.2010.07.019","article-title":"The blood\u2013brain barrier, chemokines and multiple sclerosis","volume":"1812","author":"Holman","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577398","article-title":"The neutrophil-to-lymphocyte ratio in Alzheimer\u2019s disease: Current understanding and potential applications","volume":"349","author":"Sayed","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0515","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4049\/jimmunol.1800805","article-title":"Does T cell activation require a quorum of lymphocytes?","volume":"201","author":"Al-Yassin","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0520","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3389\/fimmu.2019.01618","article-title":"IL-1 family members mediate cell death, inflammation and angiogenesis in retinal degenerative diseases","volume":"10","author":"Wooff","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0525","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1515\/revneuro-2015-0059","article-title":"Deciphering variability in the role of interleukin-1\u03b2 in Parkinson\u2019s disease","volume":"27","author":"Saghazadeh","year":"2016","journal-title":"Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0530","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0535","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-63849-6.00002-5","article-title":"HIV neuropathology","volume":"152","author":"Morgello","year":"2018"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb0540","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3390\/ijerph17041227","article-title":"Transition metal containing particulate matter promotes Th1 and Th17 inflammatory response by monocyte activation in organic and inorganic compounds dependent manner","volume":"17","author":"Ga\u0142uszka","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2025.146374_bb0545","first-page":"217","article-title":"Association between tumor necrosis factor-\u03b1 (-238G\/A and-308G\/A) gene polymorphisms and risk of ischemic stroke: a meta-analysis","volume":"3","author":"Kumar","year":"2016","journal-title":"Pulse"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0978-3","article-title":"Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties","volume":"14","author":"Prajeeth","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0555","first-page":"5314541","article-title":"Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications","volume":"2016","author":"Passos","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0560","doi-asserted-by":"crossref","DOI":"10.1177\/2055217319899695","article-title":"Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only","volume":"6","author":"Kalra","year":"2020","journal-title":"Multiple Sclerosis Journal\u2013Experimental, Translational and Clinical"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0565","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2015.00604","article-title":"Involvement of CD8+ T cells in multiple sclerosis","volume":"6","author":"Salou","year":"2015","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb0570","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/14728222.2013.815726","article-title":"CD8+ T cells in multiple sclerosis","volume":"17","author":"Denic","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0575","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.2000797","article-title":"Encephalitogenic and regulatory CD8 T cells in multiple sclerosis and its animal models","volume":"206","author":"Mockus","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101416","article-title":"Role of B cells and antibodies in multiple sclerosis","volume":"36","author":"Wanleenuwat","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0585","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/brainsci10100758","article-title":"Anti-CD20 agents for multiple sclerosis: spotlight on ocrelizumab and ofatumumab","volume":"10","author":"Florou","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0590","first-page":"1","article-title":"Rituximab for the treatment of multiple sclerosis: a review","author":"Chisari","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0595","first-page":"100932","article-title":"The role of CXCL12\/CXCR4\/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases","author":"Sarallah","year":"2024","journal-title":"Brain, Behavior, & Immunity-Health"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0600","doi-asserted-by":"crossref","first-page":"1547256","DOI":"10.3389\/fimmu.2025.1547256","article-title":"Chemokines as therapeutic targets for multiple sclerosis: a spatial and chronological perspective","volume":"16","author":"Arimitsu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0605","series-title":"The Blood-Brain Barrier in Health and Disease","first-page":"331","article-title":"Chemokines as mediators of leukocyte trafficking and activation at the blood-brain barrier","volume":"Volume One","author":"Quandt","year":"2015"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0610","first-page":"1","article-title":"Efficacy of lavender oil as an adjunctive treatment for patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial","author":"Abbasifard","year":"2025","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156235","article-title":"TNF-\u03b1\/STAT1\/CXCL10 mutual inflammatory axis that contributes to the pathogenesis of experimental models of multiple sclerosis: A promising signaling pathway for targeted therapies","volume":"168","author":"Rahmat-Zaie","year":"2023","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0620","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2353\/ajpath.2008.070918","article-title":"Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis","volume":"172","author":"McCandless","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.146374_bb0625","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2006.05.003","article-title":"A role for CXCL12 (SDF-1\u03b1) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein","volume":"177","author":"Calderon","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0630","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneurol.2008.512","article-title":"Imaging correlates of leukocyte accumulation and CXCR4\/CXCL12 in multiple sclerosis","volume":"66","author":"Moll","year":"2009","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0635","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00401-012-1034-0","article-title":"Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS","volume":"124","author":"Patel","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0640","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12974-015-0468-4","article-title":"Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin\/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease","volume":"13","author":"Zilkha-Falb","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0645","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.3390\/ijms26104752","article-title":"Estradiol promotes myelin repair in the spinal cord of female mice in a CXCR4 chemokine receptor-independent manner","volume":"26","author":"Bardy-Lagarde","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0650","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mcn.2017.09.001","article-title":"Astrocytic expression of the CXCL12 receptor, CXCR7\/ACKR3 is a hallmark of the diseased, but not developing CNS","volume":"85","author":"Puchert","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0655","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1073858416685690","article-title":"CXCL12\/CXCR4\/CXCR7 chemokine axis in the central nervous system: therapeutic targets for remyelination in demyelinating diseases","volume":"23","author":"Chu","year":"2017","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2015.11.059","article-title":"CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis","volume":"469","author":"Bao","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0665","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2012.01127.x","article-title":"Inflammatory cell trafficking across the blood\u2013brain barrier: chemokine regulation and in vitro models","volume":"248","author":"Takeshita","year":"2012","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0670","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20102010","article-title":"CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity","volume":"208","author":"Cruz-Orengo","year":"2011","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0675","first-page":"e1083","article-title":"CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis","volume":"8","author":"Marastoni","year":"2021","journal-title":"Neurology: Neuroimmunology & Neuroinflammation"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0468-4","article-title":"Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin\/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease","volume":"13","author":"Zilkha-Falb","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0685","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146374_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040231","article-title":"Distinct B cell receptor functions are determined by phosphorylation","volume":"4","author":"Robinson","year":"2006","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146374_bb0695","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.3390\/ijms24076578","article-title":"Advances in the pathogenesis and treatment of systemic lupus erythematosus","volume":"24","author":"Accapezzato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146374_bb0700","first-page":"1495","article-title":"Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus","volume":"30","author":"Mannik","year":"2003","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0705","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.rdc.2007.02.005","article-title":"Neonatal lupus syndromes","volume":"33","author":"Izmirly","year":"2007","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb0710","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.126.4.607","article-title":"Immunological studies concerning the nephritis of systemic lupus erythematosus","volume":"126","author":"Koffler","year":"1967","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0715","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0720","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4049\/jimmunol.160.1.51","article-title":"A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr\/lpr mice","volume":"160","author":"Chan","year":"1998","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb0725","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri2637","article-title":"Dysregulation of germinal centres in autoimmune disease","volume":"9","author":"Vinuesa","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0730","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0735","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejr.2020.08.001","article-title":"Serum level of CXCL 12 in patients with systemic lupus erythematosus: Is it worthy for predilection of lupus nephritis?","volume":"43","author":"Sallam","year":"2021","journal-title":"The Egyptian Rheumatologist"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0740","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/0891693021000008535","article-title":"Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression","volume":"35","author":"Sugimoto","year":"2002","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0745","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2010.01.005","article-title":"Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity","volume":"129","author":"Shah","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-015-0070-7","article-title":"IL-17 and IL-23 in lupus nephritis-association to histopathology and response to treatment","volume":"16","author":"Zickert","year":"2015","journal-title":"BMC Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0755","doi-asserted-by":"crossref","first-page":"20651","DOI":"10.1038\/srep20651","article-title":"A pathogenic IFN\u03b1, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients","volume":"6","author":"L\u00f3pez","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb0760","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3390\/pathogens11121547","article-title":"The double game played by Th17 cells in infection: host defense and immunopathology","volume":"11","author":"Paroli","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-018-0714-8","article-title":"Tregs in SLE: an update","volume":"20","author":"La Cava","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb0770","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","article-title":"Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus","volume":"72","author":"Alexander","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146374_bb0775","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int. Immunol."},{"issue":"230","key":"10.1016\/j.ijbiomac.2025.146374_bb0780","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008146","article-title":"Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue","volume":"6","author":"Liarski","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-020-00978-5","article-title":"T cell abnormalities in the pathogenesis of systemic lupus erythematosus: an update","volume":"23","author":"Chen","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb0790","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09629350124724","article-title":"Lymphocytes T\u03b3\u03b4 in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity","volume":"10","author":"Robak","year":"2001","journal-title":"Mediat. Inflamm."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb0795","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.4049\/jimmunol.1002776","article-title":"Generation of human regulatory \u03b3\u03b4 T cells by TCR\u03b3\u03b4 stimulation in the presence of TGF-\u03b2 and their involvement in the pathogenesis of systemic lupus erythematosus","volume":"186","author":"Li","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0800","doi-asserted-by":"crossref","unstructured":"Katsuyama, E., et al., The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep., 2020. 30(1): p. 112\u2013123. e4.","DOI":"10.1016\/j.celrep.2019.12.014"},{"issue":"7562","key":"10.1016\/j.ijbiomac.2025.146374_bb0805","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146374_bb0810","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/art.40038","article-title":"Signaling lymphocytic activation molecule family member 7 engagement restores defective effector CD8+ T cell function in systemic lupus erythematosus","volume":"69","author":"Comte","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb0815","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.5858\/arpa.2012-0415-OA","article-title":"Decreased expressions of Toll-like receptor 9 and its signaling molecules in chronic hepatitis B virus\u2013infected patients","volume":"137","author":"Sajadi","year":"2013","journal-title":"Arch. Pathol. Lab Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0820","doi-asserted-by":"crossref","first-page":"45","DOI":"10.33696\/immunology.5.168","article-title":"Dysregulated CXCL12 expression in osteoblasts promotes B-lymphocytes preferentially homing to the bone marrow in MRL\/lpr mice","volume":"5","author":"Zheng","year":"2023","journal-title":"Journal of Cellular Immunology"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.649693","article-title":"Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different MO","volume":"12","author":"Fresneda Alarcon","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0830","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/imr.13284","article-title":"A variety of death modes of neutrophils and their role in the etiology of autoimmune diseases","volume":"321","author":"Li","year":"2024","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146374_bb0835","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.3390\/ijms22084190","article-title":"Type I interferon production of plasmacytoid dendritic cells under control","volume":"22","author":"Bencze","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0840","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fimmu.2019.00778","article-title":"Sources of type I interferons in infectious immunity: plasmacytoid dendritic cells not always in the driver\u2019s seat","volume":"10","author":"Ali","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb0845","doi-asserted-by":"crossref","first-page":"14158","DOI":"10.3390\/ijms160614158","article-title":"A plasmacytoid dendritic cells-type I interferon axis is critically implicated in the pathogenesis of systemic lupus erythematosus","volume":"16","author":"Kim","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0850","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-biochem-032620-104401","article-title":"Mitochondrial DNA release in innate immune signaling","volume":"92","author":"Newman","year":"2023","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0855","article-title":"Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0860","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s43556-024-00217-8","article-title":"Systemic lupus erythematosus: pathogenesis and targeted therapy","volume":"5","author":"Su","year":"2024","journal-title":"Molecular Biomedicine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb0865","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.27685","article-title":"Dysregulated expression of CXCR4\/CXCL12 in subsets of patients with systemic lupus erythematosus","volume":"62","author":"Wang","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0870","series-title":"Peripheral Hematopoiesis in Systemic Lupus Erythematosus: Molecular and Functional Analysis","author":"Zervopoulou","year":"2022"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0875","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000514913","article-title":"The role of CXCL12 in kidney diseases: a friend or foe?","volume":"7","author":"Song","year":"2021","journal-title":"Kidney Diseases"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb0880","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-019-0323-6","article-title":"Chemokines in rheumatic diseases: pathogenic role and therapeutic implications","volume":"15","author":"Miyabe","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb0885","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/cells13121027","article-title":"Crosstalk between CXCL12\/CXCR4\/ACKR3 and the STAT3 pathway","volume":"13","author":"Ma","year":"2024","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0890","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/cmi.2016.47","article-title":"Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus","volume":"14","author":"Zhao","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb0895","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.yexcr.2013.03.030","article-title":"SDF-1\u03b1 reduces fibronectin expression in rat mesangial cells induced by TGF-\u03b21 and high glucose through PI3K\/Akt pathway","volume":"319","author":"Zhang","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-10-251","article-title":"Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic lupus erythematosus","volume":"10","author":"Biajoux","year":"2012","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0905","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jgh3.12706","article-title":"Immune-mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis","volume":"6","author":"Vuyyuru","year":"2022","journal-title":"JGH Open"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0910","first-page":"21","article-title":"Pathogenesis of inflammatory bowel disease","volume":"20","author":"Dolu","year":"2025","journal-title":"Pathogenesis"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0915","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/1040841X.2021.1876631","article-title":"Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium","volume":"47","author":"Ahlawat","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0920","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1954","article-title":"A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1","volume":"39","author":"Hampe","year":"2007","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0925","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease","volume":"49","author":"De Lange","year":"2017","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0930","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0935","doi-asserted-by":"crossref","first-page":"1171680","DOI":"10.3389\/fimmu.2023.1171680","article-title":"Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0945","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/mi.2013.60","article-title":"Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells","volume":"7","author":"Bishop","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb0950","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08830185.2021.1895145","article-title":"Innate lymphoid cells and adaptive immune cells cross-talk: a secret talk revealed in immune homeostasis and different inflammatory conditions","volume":"40","author":"Kumar","year":"2021","journal-title":"Int. Rev. Immunol."},{"issue":"31","key":"10.1016\/j.ijbiomac.2025.146374_bb0955","doi-asserted-by":"crossref","first-page":"12768","DOI":"10.1073\/pnas.1300318110","article-title":"IL-22\u2013producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis","volume":"110","author":"Zindl","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0960","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cytogfr.2022.07.005","article-title":"The involvement of TH17 cells in the pathogenesis of IBD","volume":"69","author":"Jiang","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb0965","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution","volume":"129","author":"Heller","year":"2005","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb0970","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/gut.2007.130112","article-title":"The role of the novel Th17 cytokine IL-26 in intestinal inflammation","volume":"58","author":"Dambacher","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb0975","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/mi.2013.31","article-title":"IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue","volume":"7","author":"Leung","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146374_bb0980","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146374_bb0985","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb0990","doi-asserted-by":"crossref","first-page":"1100869","DOI":"10.3389\/fimmu.2023.1100869","article-title":"Chemokines and chemokine receptors as promising targets in rheumatoid arthritis","volume":"14","author":"Murayama","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb0995","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2006.108043","article-title":"New serological markers in inflammatory bowel disease are associated with complicated disease behaviour","volume":"56","author":"Ferrante","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1000","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/00365520903483650","article-title":"Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn\u2019s disease treatment","volume":"45","author":"Sipponen","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb1005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/14737159.2018.1516549","article-title":"Molecular diagnosis and classification of inflammatory bowel disease","volume":"18","author":"Zhang","year":"2018","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146374_bb1010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ibd.20376","article-title":"Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease","volume":"14","author":"Walkiewicz","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","article-title":"Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease","volume":"119","author":"Tibble","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb1020","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/gast.2001.23966","article-title":"ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease","volume":"120","author":"Taylor","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7150\/thno.5135","article-title":"Involvement of CXCR4\/CXCR7\/CXCL12 interactions in inflammatory bowel disease","volume":"3","author":"Werner","year":"2013","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ibd.21106","article-title":"CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system","volume":"16","author":"Dotan","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1189\/jlb.0111101","article-title":"Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease","volume":"90","author":"Werner","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"42","key":"10.1016\/j.ijbiomac.2025.146374_bb1040","doi-asserted-by":"crossref","first-page":"35760","DOI":"10.1074\/jbc.M508234200","article-title":"The chemokine SDF-1\/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes","volume":"280","author":"Balabanian","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb1045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20071903","article-title":"Essential but differential role for CXCR4 and CXCR7 in the therapeutic homingof human renal progenitor cells","volume":"205","author":"Mazzinghi","year":"2008","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1050","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1189\/jlb.0208088","article-title":"A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells","volume":"84","author":"Hartmann","year":"2008","journal-title":"Journal of Leucocyte Biology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.12.034","article-title":"Control of chemokine-guided cell migration by ligand sequestration","volume":"132","author":"Boldajipour","year":"2008","journal-title":"Cell"},{"issue":"34","key":"10.1016\/j.ijbiomac.2025.146374_bb1060","doi-asserted-by":"crossref","first-page":"23189","DOI":"10.1074\/jbc.M803947200","article-title":"Small neutralizing molecules to inhibit actions of the chemokine CXCL12","volume":"283","author":"Hachet-Haas","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1065","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/ibd\/izae255","article-title":"Stromal cell subsets show model-dependent changes in experimental colitis and affect epithelial tissue repair and immune cell activation","volume":"31","author":"Zhou","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.655887","article-title":"Noncanonical NF-\u03baB signaling upregulation in inflammatory bowel disease patients is associated with loss of response to anti-TNF agents","volume":"12","author":"Nguyen","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2014.05.001","article-title":"Pathological activation of canonical nuclear-factor \u03baB by synergy of tumor necrosis factor \u03b1 and TNF-like weak inducer of apoptosis in mouse acute colitis","volume":"69","author":"Dohi","year":"2014","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb1080","doi-asserted-by":"crossref","first-page":"G140","DOI":"10.1152\/ajpgi.00022.2024","article-title":"Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models","volume":"327","author":"\u00d6hnstedt","year":"2024","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1085","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.22439","article-title":"Up-regulation of stromal cell\u2013derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L\u2013CD40 interaction","volume":"56","author":"Kim","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/cells11030452","article-title":"miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis","volume":"11","author":"Kmio\u0142ek","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146374_bb1095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/etm.2021.9890","article-title":"microRNA-23 inhibits inflammation to alleviate rheumatoid arthritis via regulating CXCL12","volume":"21","author":"Gao","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146374_bb1100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.9890","article-title":"microRNA-23 inhibits inflammation to alleviate rheumatoid arthritis via regulating CXCL12","volume":"21","author":"Gao","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"05","key":"10.1016\/j.ijbiomac.2025.146374_bb1105","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1142\/S0192415X03001430","article-title":"Suppressive effects of a Chinese herbal medicine Qing-Luo-Yin extract on the angiogenesis of collagen-induced arthritis in rats","volume":"31","author":"Li","year":"2003","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1110","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/13880209.2021.1991386","article-title":"Qingluoyin granules protect against adjuvant-induced arthritis in rats via downregulating the CXCL12\/CXCR4-NF-\u03baB signalling pathway","volume":"59","author":"Si","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1115","series-title":"Qingluoyin Granules Protect Against Adjuvant-induced Arthritis in Rats via Downregulating the CXCL12\/CXCR4-NF-KB Signalling Pathway","author":"Si","year":"2021"},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.146374_bb1120","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1021\/acs.jmedchem.1c00852","article-title":"Systematic development of peptide inhibitors targeting the CXCL12\/HMGB1 interaction","volume":"64","author":"Sgrignani","year":"2021","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb1125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.31083\/j.fbl2812337","article-title":"A study on the pharmacological effects and mechanism of Rhodojaponin III in rheumatoid arthritis","volume":"28","author":"Liu","year":"2023","journal-title":"Frontiers in Bioscience-Landmark"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146374_bb1130","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22551","article-title":"Rhodojaponin II inhibits TNF-\u03b1-induced inflammatory cytokine secretion in MH7A human rheumatoid arthritis fibroblast-like synoviocytes","volume":"34","author":"Kong","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1135","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ard.2004.024927","article-title":"Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF\u03b1 and IL18 but not CXCL12","volume":"64","author":"Van Oosterhout","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb1140","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cyto.2013.02.023","article-title":"Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients","volume":"62","author":"Pav\u00f3n","year":"2013","journal-title":"Cytokine"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.146374_bb1145","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.1006375107","article-title":"Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis","volume":"107","author":"Carbajal","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1150","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.csbj.2025.04.023","article-title":"A potent nonapeptide inhibitor for the CXCL12\/HMGB1 heterocomplex: A computational and experimental approach","volume":"27","author":"Fassi","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb1155","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1084\/jem.20080730","article-title":"CXCL12 (SDF-1\u03b1) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells","volume":"205","author":"Moran Meiron","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1160","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fimmu.2020.01057","article-title":"HMGB1 in systemic lupus erythematosus","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.146374_bb1165","first-page":"3018","article-title":"Effects of allogeneic bone marrow mesenchymal stem cells infusion on the expression of CXCL12\/CXCR4 in the kidney of MRL\/lpr lupus mice","volume":"26","author":"Cheng","year":"2022","journal-title":"Chinese Journal of Tissue Engineering Research"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2016.07.003","article-title":"Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis","volume":"169","author":"Devarapu","year":"2016","journal-title":"Clin. Immunol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.146374_bb1175","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1002\/1878-0261.13218","article-title":"miR-126 downregulates CXCL12 expression in intestinal epithelial cells to suppress the recruitment and function of macrophages and tumorigenesis in a murine model of colitis-associated colorectal cancer","volume":"16","author":"Wu","year":"2022","journal-title":"Mol. Oncol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.146374_bb1180","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1111\/jcmm.16460","article-title":"miR-126-3p is essential for CXCL12-induced angiogenesis","volume":"25","author":"Bassand","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146374_bb1185","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/gutjnl-2012-304213","article-title":"miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12\u03b2 during murine colitis and human Crohn's disease","volume":"63","author":"Huang","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1410104","article-title":"The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?","volume":"15","author":"Abbasifard","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5978\/islsm.20.53","article-title":"Reduction of CXCR4 expression in rheumatoid arthritis rat joints by low level diode laser irradiation","volume":"20","author":"Zhang","year":"2011","journal-title":"Laser therapy"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1200","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbrc.2020.03.164","article-title":"Paeoniflorin-6\u2032-O-benzene sulfonate down-regulates CXCR4-G\u03b2\u03b3-PI3K\/AKT mediated migration in fibroblast-like synoviocytes of rheumatoid arthritis by inhibiting GRK2 translocation","volume":"526","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1205","series-title":"Low dose methotrexate impaired T cell transmigration through down-regulating CXCR4 expression in Rheumatoid Arthritis","author":"Ding","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1806","article-title":"Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis","volume":"7","author":"De Klerck","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1215","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.40230","article-title":"NF-\u03baB2 controls the migratory activity of memory T cells by regulating expression of CXCR4 in a mouse model of Sj\u00f6gren's syndrome","volume":"69","author":"Kurosawa","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1220","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/jcb.23043","article-title":"Stromal cell-derived factor-1\/CXCR4 promotes IL-6 production in human synovial fibroblasts","volume":"112","author":"Chen","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"828","key":"10.1016\/j.ijbiomac.2025.146374_bb1225","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abl3758","article-title":"CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans","volume":"17","author":"White","year":"2024","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1230","doi-asserted-by":"crossref","first-page":"1254697","DOI":"10.3389\/fimmu.2023.1254697","article-title":"CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling","volume":"14","author":"Giblin","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1235","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1152\/ajpendo.00083.2012","article-title":"CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor","volume":"304","author":"Lee","year":"2013","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1240","series-title":"CXCL17 Is an Endogenous Inhibitor of CXCR4 via a Novel Mechanism of Action","author":"White","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1245","first-page":"180","article-title":"The CXCL12\/CXCR4 and VEGF165\/Nrp1 pathways have differential effects on pathological neo-angiogenesis and vascular remodeling in hemophilic arthropathy","volume":"130","author":"Wyseure","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1250","doi-asserted-by":"crossref","first-page":"1105530","DOI":"10.3389\/fnins.2023.1105530","article-title":"Upregulation of CXC motif chemokine 12 in the spinal cord alleviated the symptoms of experimental autoimmune encephalomyelitis in Lewis rats","volume":"17","author":"Lin","year":"2023","journal-title":"Front. Neurosci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb1255","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.4049\/jimmunol.177.11.8053","article-title":"CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis","volume":"177","author":"McCandless","year":"2006","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb1260","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.imbio.2011.03.013","article-title":"CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats","volume":"216","author":"Miljkovi\u0107","year":"2011","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146374_bb1265","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4103\/NRR.NRR-D-24-00439","article-title":"Crosstalk between androgen signaling and the chemokine receptor CXCR4: a novel strategy to promote myelin regeneration","volume":"20","author":"Bardy-Lagarde","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146374_bb1270","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41419-024-06708-4","article-title":"Macrophages communicate with mesangial cells through the CXCL12\/DPP4 axis in lupus nephritis pathogenesis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1275","doi-asserted-by":"crossref","first-page":"1490593","DOI":"10.3389\/fimmu.2024.1490593","article-title":"The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models","volume":"15","author":"Bekaddour","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1280","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e25","article-title":"Mitochondria activity and CXCR4 collaboratively promote the differentiation of CD11c+ B cells induced by TLR9 in lupus","volume":"24","author":"Jang","year":"2024","journal-title":"Immune Netw."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb1285","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.108.141085","article-title":"Blockade of CXCL12\/CXCR4 axis ameliorates murine experimental colitis","volume":"327","author":"Mikami","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1290","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s11011-022-01155-6","article-title":"CXCR4 as possible druggable target linking inflammatory bowel disease and Parkinson\u2019s disease","volume":"38","author":"Dogra","year":"2023","journal-title":"Metab. Brain Dis."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.146374_bb1295","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3748\/wjg.v16.i23.2873","article-title":"CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis","volume":"16","author":"Xia","year":"2010","journal-title":"World J Gastroenterol: WJG"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146374_bb1300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027282","article-title":"CXCR4 antagonist AMD3100 modulates claudin expression and intestinal barrier function in experimental colitis","volume":"6","author":"Xia","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1305","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbrc.2018.03.043","article-title":"Dual expression of CXCR4 and IL-35 enhances the therapeutic effects of BMSCs on TNBS-induced colitis in rats through expansion of Tregs and suppression of Th17 cells","volume":"499","author":"Nan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146374_bb1310","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/labinvest.2011.77","article-title":"Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular-regulated kinase-1\/2 in restitution","volume":"91","author":"Zimmerman","year":"2011","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2024.100134","article-title":"Discovery of dibenzyl amide derivatives as novel CXCR4 modulators against inflammatory bowel disease","volume":"10","author":"Jiang","year":"2024","journal-title":"European Journal of Medicinal Chemistry Reports"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb1320","doi-asserted-by":"crossref","first-page":"10057","DOI":"10.1021\/acs.jmedchem.4c00184","article-title":"Synthetically feasible de novo molecular design of leads based on a reinforcement learning model: AI-assisted discovery of an anti-IBD lead targeting CXCR4","volume":"67","author":"Jiang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1325","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/annrheumdis-2019-215696","article-title":"FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice","volume":"79","author":"Kuang","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.146374_bb1330","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1074\/jbc.M112.426254","article-title":"Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome","volume":"288","author":"Rajam\u00e4ki","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146374_bb1335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41419-021-04455-4","article-title":"The proton-activated G protein-coupled receptor GPR4 regulates the development of osteoarthritis via modulating CXCL12\/CXCR7 signaling","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2022.12594","article-title":"C-X-C receptor 7 agonist acts as a C-X-C motif chemokine ligand 12 inhibitor to ameliorate osteoclastogenesis and bone resorption","volume":"25","author":"Nugraha","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.146374_bb1345","doi-asserted-by":"crossref","first-page":"11592","DOI":"10.3390\/ijms222111592","article-title":"Mesenchymal stem cell-based therapy for rheumatoid arthritis","volume":"22","author":"Sarsenova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1350","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13287-021-02402-w","article-title":"Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation","volume":"12","author":"Wei","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1355","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/138945012799499749","article-title":"Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells","volume":"13","author":"Chen","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-8-170","article-title":"CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity","volume":"8","author":"Cruz-Orengo","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1365","doi-asserted-by":"crossref","first-page":"e21431","DOI":"10.1096\/fj.202002465R","article-title":"ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases","volume":"35","author":"Pouzol","year":"2021","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146374_bb1370","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/bph.12565","article-title":"Blocking initial infiltration of pioneer CD 8+ T-cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice","volume":"171","author":"Luo","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1375","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3892\/ijo.2014.2547","article-title":"Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer through ERK and \u03b2-arrestin pathways","volume":"45","author":"Li","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146374_bb1380","doi-asserted-by":"crossref","first-page":"e21260","DOI":"10.1096\/fj.202001273R","article-title":"Polyfunctionality of the CXCR4\/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune-mediated diseases","volume":"35","author":"Britton","year":"2021","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1385","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/0122103031304556240430161553","article-title":"From conventional to cutting-edge: a comprehensive review on drug delivery systems","volume":"14","author":"Vikal","year":"2024","journal-title":"Drug Deliv. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12355-023-01352-2","article-title":"CRISPR\/Cas-mediated genome editing for sugarcane improvement","volume":"27","author":"Mall","year":"2025","journal-title":"Sugar Tech"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146374_bb1395","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/biotech11030025","article-title":"Closing the door with CRISPR: genome editing of CCR5 and CXCR4 as a potential curative solution for HIV","volume":"11","author":"Freen-van Heeren","year":"2022","journal-title":"BioTech"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb1400","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.3892\/or.2017.5601","article-title":"CRISPR\/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1405","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.2147\/OTT.S195661","article-title":"Impact of CXCR4 and CXCR7 knockout by CRISPR\/Cas9 on the function of triple-negative breast cancer cells","author":"Yang","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146374_bb1410","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/cancers13122929","article-title":"Biparatopic protein nanoparticles for the precision therapy of CXCR4+ cancers","volume":"13","author":"Cano-Garrido","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1415","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1021\/acsabm.5c00489","article-title":"Nanotechnology-enhanced siRNA delivery: revolutionizing cancer therapy","volume":"8","author":"Esmaeilpour","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116605","article-title":"Discovery of novel CXCR4 inhibitors for the treatment of inflammation by virtual screening and biological evaluation","volume":"275","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146374_bb1425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-025-02977-x","article-title":"GliaTrap is a biodegradable, non-swelling and non-inflammatory hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells","volume":"15","author":"Suita","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.146374_bb1430","doi-asserted-by":"crossref","first-page":"1561112","DOI":"10.3389\/fphar.2025.1561112","article-title":"Mechanism underlying the involvement of CXCR4\/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb1435","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/1061186X.2024.2345235","article-title":"A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy","volume":"32","author":"Alcantara","year":"2024","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146374_bb1440","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4236\/jct.2021.126029","article-title":"CXCL12 retargeting of an oncolytic adenovirus vector to the chemokine CXCR4 and CXCR7 receptors in breast cancer","volume":"12","author":"O\u2019Bryan","year":"2021","journal-title":"J. Cancer Ther."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025069314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025069314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:01:22Z","timestamp":1757628082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025069314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":287,"alternative-id":["S0141813025069314"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146374","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stromal-derived factor-1: The glycoprotein fueling autoimmune storms via CXCR4 and CXCR7","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"146374"}}